Results 71 to 80 of about 53,967 (290)

Methamphetamine use among people accessing opioid agonist treatment in Australia, 2014 - 2024 [PDF]

This bulletin seeks to explore: i) trends in methamphetamine use among individuals receiving opioid agonist treatment, and ii) whether demographic and treatment characteristics differ among OAT clients who are and are not using ...
Tayeb, Haniene, Sutherland, Rachel ; https://orcid.org/, Peacock, Amy   +2 more
core   +1 more source

Addressing in‐hospital substance use: A bioethical evaluation of two possible approaches

Journal of Hospital Medicine, EarlyView.
Abstract Up to 40% of patients with substance use disorder report using non‐prescribed drugs when hospitalized. In‐hospital substance (IHSU) use is associated with poor outcomes and raises safety concerns for healthcare providers. Despite its prevalence, little guidance exists regarding best practices in responding to IHSU.
John C. Messinger, Taylor Baisey, Johanna Sluser, Benjamin A. Barsky, Marlene Martin, Leslie W. Suen   +5 more
wiley   +1 more source

Meth in Allegan County -- Spreading to West Michigan? [PDF]

, 2008
According to the Office of National Drug Policy, White House, about 1.3 million people used meth in the year 2002. Moreover, in 2001, 607,000 people used methamphetamine.
Mishra, Jitendra M
core  

RAFT Copolymerization of DMAEA and AETAC Toward Charge‐Shifting Copolymers With Tunable Heparin Complexation

Macromolecular Rapid Communications, EarlyView.
Copolymers based on charge‐shifting (DMAEA) and permanently charged (AETAC) cationic acrylates were copolymerized via the RAFT process to achieve polycations with well‐defined composition. Moderate content of AETAC did not affect hydrolysis rates but significantly enhanced heparin binding.
Radoslava Sivkova, Monika Matiyani, Andrii Mahun, Volodymyr Lobaz, Gabriela Sarahí García‐Briones, Dana Kubies   +5 more
wiley   +1 more source

COVID‐19 Amplifies Sex‐Specific Dopamine and Glial Responses in a Parkinson's Disease Mouse Model

Movement Disorders, EarlyView.
Abstract Background Exposure to environmental agents, including viral infections, may increase Parkinson's disease (PD) susceptibility, especially in males, but the neurodegenerative risk extent of COVID‐19 remains uncertain. Objectives We investigated the plausible link between severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and
Ifeoluwa Awogbindin, Mélanie Bourque, Marc Morissette, Marie‐Ève Hamelin, Chantal Rhéaume, Jared VanderZwaag, Antonia Landwehr, Disha Patel, Guy Boivin, Marie‐Ève Tremblay, Thérèse Di Paolo   +10 more
wiley   +1 more source

Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: evidence from a prospective cohort study

, 2020
Methamphetamine has been consistently associated with positive psychotic symptoms, but little is known about whether the reverse also occurs.This study determined whether the relationship between methamphetamine use and positive psychotic symptoms is ...
Kavanagh, David J., Saunders, John B, Saunders, John B., Young, Ross McD, Kavanagh, David J, Chan, Gary, Teesson, Maree, Dawe, Sharon, McKetin, Rebecca, Hides, Leanne   +9 more
core   +1 more source

Environmental enrichment has no effect on the development of dopaminergic and GABAergic fibers during methylphenidate treatment of early traumatized gerbils [PDF]

, 2008
Brummelte S, Grund T, Moll GH, Teuchert-Noodt G, Dawirs RR. Environmental enrichment has no effect on the development of dopaminergic and GABAergic fibers during methylphenidate treatment of early traumatized gerbils.
Teuchert-Noodt, Gertraud, Moll, Gunther H., Susanne Brummelte, Gertraud Teuchert-Noodt, Ralph R Dawirs, Dawirs, Ralph R., Gunther H Moll, Grund, Thorsten, Thorsten Grund, Brummelte, Susanne   +9 more
core   +2 more sources

Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)‐VK4‐116, as a Non‐Opioid Medication for the Treatment of Opioid Use Disorder

Medicinal Research Reviews, EarlyView.
ABSTRACT Opioid use disorder (OUD) remains a major global health challenge, and currently approved treatments (methadone, buprenorphine, and naltrexone) are all opioid receptor‐targeting drugs with limitations in access, adherence, stigma, and use in polysubstance use disorders. Because the dopamine D3 receptor (D3R) is enriched in limbic brain regions
Chia‐Kuei Wu, Yu‐Chih Lin, Junfeng Huang, Bangwei Ding, Pramod Terse, Rahul Nandre, Haksong Jin, Molly Congdon, Kun Shen, Philip Sanderson, Gregory Tawa, Stephanie Mounaud, Marta De Santis, Donald Lo, Elizabeth A. Ottinger, Amy Hauck Newman   +15 more
wiley   +1 more source

Metabolic Abnormalities in Abstinent Methamphetamine Dependent Subjects

, 2010
Introduction: Chronic methamphetamine use results in persistent neuropsychological deficits in abstinent methamphetamine dependent (AMD) subjects.
Martha Hernandez, Poone Haghani, Osama Abulseoud, Napapon Sailasuta, Brian D Ross   +4 more
core   +1 more source

Diverse reactivity of maleimides in polymer science and beyond

Polymer International, Volume 74, Issue 4, Page 296-306, April 2025.
This mini‐review provides a thorough overview of maleimide chemistry, highlighting its diverse reactivity in polymer and materials science applications. Abstract Maleimides are remarkably versatile functional groups, capable of participating in homo‐ and copolymerizations, Diels–Alder and (photo)cycloadditions, Michael additions, and other reactions ...
Bruce E Kirkpatrick, Kristi S Anseth, Tayler S Hebner   +2 more
wiley   +1 more source